Focus on improving our planet.
Let's collaborate for sustainability &
digitalization.

Open innovation Platform for sustainability.
Find the right opportuinty and grow up your
innovation ecosystem.

Sign in/up

Search an
opportunity

Do you want to be part of innovative a sustainable project? Search for your opportunity and make your contribution to for the sustainable growth of the economy and the planet.

Tech collaborations
Joint Ventures
Licensing
Subcontracting
Investment

Express interest
GMP (Good manufacturing practice) production of cell therapy...
created · Updated
Deadline: Jun 12, 2022
Received 0 expressions of interest

Summary

A Spanish (Basque) biopharmaceutical SME focused on the discovery, development, production and commercialization of new cell therapy and tissue engineering products for Regenerative Medicine is exploring strategic and financial alternatives based on partners’ collaborations, services, licenses and/or commercial agreements to develop proprietary cell therapy products and to provide GMP (Good manufacturing practice) cell production services to companies, hospitals and institutions.

Description

The Basque biopharmaceutical SME is an authorized ATMP (advanced therapy medicinal products) manufacturing laboratory for its proprietary cell therapy pipeline as well as for third-party production services. Pipeline refers to the products the company has under development.

The company’s facilities include a GMP manufacturing Unit of cell therapy medicines and biological associated products certified by the Spanish drug and medical device agency (AEMPS).

Currently implemented GMP certified processes include both autologous and allogenic mesenchymal stem cells from bone marrow or from adipose tissue and chondrocyte production, as well as its proprietary Cell Therapy Technology Platform: Adipose derived stem cells that have overcome a preconditioning process that enables them to respond with enhanced potential under pro-inflammatory environments. Nowadays, the company is expanding and is ready to produce other cellular products in its GMP facilities and biological associated products (secretomes, conditioned media or exosomes).

Company’s customers include hospitals, biotech and pharmaceutical companies conducting cell therapy-based clinical trials. Regenerative medicine is an emerging and innovative field with several clinical trials ongoing for different indications. The company has the technological, regulatory and commercial experience to capture this growing opportunity, therefore, the necessary skills combined with adequate personnel and facilities for GMP production of final or intermediate cellular products.
The technology offered by this SME is very convenient for those organizations that are not specialized in cell therapy manufacturing but who are interested in the clinical application of adult stem cells.

The company is looking for strategic and financial agreements with partners to complete the development and launch of new products based on its proprietary cell therapy pipeline, as well as for organizations interested in contracting the GMP production service of cell therapy products.

Advantages & innovations

The GMP (Good manufacturing practice) production of cell therapy products requires a huge investment in the facilities, technology, regulatory issues and highly specialized personnel. The main advantage of working with this SME is to avoid this huge and time-consuming investment in customers not specialized in producing but interested in the clinical application of adult stem cells. The company has both the capabilities for GMP production of cell therapy products and the know-how to apply this technology in a patented proprietary cell therapy technology platform. The company has several "Certificates of GMP Compliance of a Manufacturer" for different types of autologous and allogenic fat stem adult mesenchymal cells.

Stage of development

Already on the market

Partner sought

The company wishes to collaborate with biotechnology companies, research centres and Hospitals active in the biotechnological sector, particularly, in regenerative medicine. They are looking for strategic and financial opportunities based on collaborations, licenses and/or commercial agreements with technical assistance to develop proprietary cell therapy products and to provide GMP cell production services to third companies, hospitals and institutions, both public or private.

Create an
opportunity

Show your project-opportunity to generate interest of potential partners or collaborators. Companies, freelancers, or research centers can meet in Nir-vana and become perfect team together!

Latest Opportunities

EIT Food Public Engagement Proof of Concepts Call for Proposals 2023,...

published
Deadline: Aug 15, 2024
Project full name: EIT Food Public Engagement Proof of Concepts Call for Proposals 2023, 2024, 2025
Project acronym: EIT Food PE PoC Call 2023, 2024, 2025
Grant agreement number: N/A
Total EU funding available: €360 000 per submission window (total for 3 rounds: €1 380 000)
By the date of the Calls’ launches a webpage will be activated at eitfood.eu/projects/public-engagement-proof-of-concepts-call

Join and create
your ecosystem

Meet and connect with experts from around the world. Generate your innovative ecosystem and interact with them thanks to the different functionalities of Nir-vana: exchange spaces, lists of opportunities, expression of interest

Bénédicte Ganivet
Juan Manuel López García
Build your project with
the best professionals
in the sector
Latest Opportunities

    EIT Food Public Engagement Proof of Concepts Call for Proposals 2023,...

    published
    Deadline: Aug 15, 2024
    Project full name: EIT Food Public Engagement Proof of Concepts Call for Proposals 2023, 2024, 2025
    Project acronym: EIT Food PE PoC Call 2023, 2024, 2025
    Grant agreement number: N/A
    Total EU funding available: €360 000 per submission window (total for 3 rounds: €1 380 000)
    By the date of the Calls’ launches a webpage will be activated at eitfood.eu/projects/public-engagement-proof-of-concepts-call
    Swedish SME in the hygiene sector produces washable re-usable absorbent underwear helping people with little leaks such as incontinence (urine escape due to bladder weakness) or other forms of leakage during periods or pregnancy. Compared to disposable products they are environmentally sustainable, less costly, providing a sense of normalisation and comfort for users. The SME is looking for sales agents, retailers, distributors interested in entering business collaboration agreements
    Company based in Sweden, is a pioneering force in digital cleaning training, specializing in e-learning for cleaners, supervisors, and clients. With a proven track record since 1994 and a recent foray into international markets, companyseeks strategic partnerships in Europe.
    Spanish company manufacturing vinegars, lemon juice, food dressings, balsamic creams and other related products in different types of containers and different formats and weights, is looking for wholesaler or distributor. Preferred channels: supermarkets, large distribution, convenience stores, hospitality services (hotels, restaurants and catering), gourmet shops and others.

The most relevant open & connected
network for sustainable business development.

Join now!

Sustainable
projects

Nir-vana wants to be the first open innovation platform focus on sustainability.

According to the EU Action Plan there is a huge need of change to a more sustainable future and to collaborate and assure to achieve the SDG.

Network
& experts

Nir-vana is the only platform integrating seamless "search and find" to the next stage of collaborating.

Get connected with experts and companies for partnering. Find trusted innovation advisors, certified by Enterprise Europe Network and build up your team of partners, companies and experts you need for your innovation.

Find public funding &
private investors

Discover potential funding opportunities for your innovation. On nir-vana you have access to national and EU funding programmes, public funding and private investors.

Get connected to consultants and advisors specialised on funding and grant preparation.